Paul Singh’s Post

The PT industry needs more transparency so we're sharing our data. Here's operational benchmark data for PT practices in Florida - Let's dive in ⬇️ Average days until documentation completion - 2.58 days Average units per visit - 4.024 First pass clean claim rate - 98.03% (average) Denial Rate - 5.75% (average) Average Reimbursement Per Visit - $98.85 Top Payers in Florida: Aetna - $151.92 paid in 44 days Railroad Medicare - $146.99 paid in 14 days Florida Medicare - $108.62 paid in 14 days VA Community Care - $104.16 paid in 4 days Curious to see more benchmark data like this for other states? Comment "StrataPT" below and I'll DM you a link to them! #physicaltherapy

The PT industry needs more transparency so we're sharing our data. Here's operational benchmark data for PT practices in Georgia - Let's dive in 👇 Average days until documentation completion - 0.99 days Average units per visit - 3.159 First pass clean claim rate - 98.36% (average) Denial Rate - 5.07% (average) Average Reimbursement Per Visit - $81.70 Top Payers in GA: Medicare of GA - $100.21 paid in 18 days BCBS of GA - $95.58 paid in 12 days Tricare East - 82.13 paid in 4 days VA Community Care - $79.43 paid in 5 days Curious to see more benchmark data like this for other states? Comment "StrataPT" below and I'll DM you a link to them! #physicaltherapy

We're committed to increasing transparency in the PT industry, so here’s some valuable operational benchmark data for PT practices in Texas - Let's take a look 👇 Average days until documentation completion - 6.74 days Average units per visit - 3.784 First pass clean claim rate - 96.34% (average) Denial Rate - 9.82% (average) Average Reimbursement Per Visit - $91.58 Top Payers in TX: Aetna - $149.79 BCBS Texas - $127.72 BCBS Texas Medicare Advantage - $91.58 Curious to see more benchmark data like this for other states? Comment "StrataPT" below and I'll DM you a link to them! #physicaltherapy #datatransparency

The PT industry needs more transparency so we're sharing our data. Here's operational benchmark data for PT practices in California - Let's dive in 👇 Average days until documentation completion - 5.16 days Average units per visit - 3.021 First pass clean claim rate - 97.01% (average) Denial Rate - 4.3% (average) Average Reimbursement Per Visit - $86.58 Top Payers in CA: CA Medicare South - $107.45 MedRisk - $106.04 Align Networks - $89.06 American Speciality Health - $87.78 Curious to see more benchmark data like this for other states? Comment "StrataPT" below and I'll DM you a link to them! #physicaltherapy

Sharing data is key if we want the PT industry to evolve. That's why we're sharing our data. Here's operational benchmark data for PT practices in Texas - Let's dive in 👇 Average days until documentation completion - 4.38 days Average units per visit - 3.857 First pass clean claim rate - 96.61% (average) Denial Rate - 8.47% (average) Average Reimbursement Per Visit - $95.66 Top Payers in TX: Aetna - $137.23 paid in 5 days WellMed - $125.45 paid in 23 days BCBS of Texas- $110.34 paid in 14 days Medicare - $102.97 paid in 16 days Curious to see more benchmark data like this for other states? Comment "StrataPT" below and I'll DM you a link to them! #physicaltherapy #healthcare

Part 2 of our webinar series is now available! 🎥 William Sarraille, renowned healthcare legal expert, breaks down the practical implications of the upcoming #Medicare changes and shares valuable tips on maximizing benefits and minimizing out-of-pocket costs. Watch the recording here: https://lnkd.in/eRD7Xp2w #HealthcareEducation #AccessiaHealth #HealthcareAccess #InflationReductionAct #Pharmacy #Medications

Always great to sit down and chat with Paul Singh from StrataPT 🦈 In this conversation, we dive into: 1. Identifying & mitigating choke points within your clinic’s cash flow  2. The importance of cash reserves  3. And why you MUST be thinking about diversifying revenue streams Conversation Highlight: “I get a little nervous whenever one single-payer gets above 20 to 25%. We’re in network with two dozen insurance companies – that should be spread loaded.” https://lnkd.in/eZxNnV7h #healthcare #healthcarebusiness #physicaltherapy #occupationaltherapy #privatepractice #cashflow #financials

My new post shows how referral rejection rates support my research on cost reports and declining margins for HHAs and how they contradict the same measures published by CMS and MedPAC. https://lnkd.in/gehkbdMa

💊 Not Breaking News, But Still a Big Deal: Medicare to Negotiate Ozempic Prices 💥 While it’s not fresh off the press, Medicare’s move to negotiate Ozempic prices is a significant shift that could reshape drug costs and access for millions. Will this push for affordability change the game, or just stir the pot? 🔍 Dive into the latest PoundsPunch for the full story: https://lnkd.in/gnMkWQmq #Ozempic #Medicare #DrugPricing #PoundsPunch

Recently, Cencora’s Reimbursement and Policy Insights team partnered with fellow expert Jennifer Snow and the Medicare Access for Patients Rx (MAPRx) coalition to publish a white paper focused on the Inflation Reduction Act’s unintended consequences. You can access the white paper here: https://lnkd.in/ePGhZMkA While IRA’s Part D benefit redesign will alleviate affordability challenges for many Part D beneficiaries, the law could have significant downstream impacts for patient access within the benefit. In the paper, we explore the following potential access challenges for Part D beneficiaries. ·      Increase in Part D monthly plan premiums ·      Narrower formulary coverage ·      Increase in utilization management ·      Reduced standalone prescription drug plan availability Given these impacts, Part D beneficiaries may face greater access challenges despite the ease in their overall out-of-pocket (OOP) cost burden, necessitating patient organizations and patient support programs to be nimble in their approach for how they are supporting patients into next year. As we learn more learn more about how the Part D market is changing in 2025 over the coming weeks, Cencora’s consulting team is here to offer our insights on the impact to market and patient access.